COMPASS Pathways

Mental health care company pioneering the development of psilocybin therapy COMP360 for treatment-resistant depression and other mental health conditions, with FDA breakthrough therapy designation.

Location
London, United Kingdom
Founded
2016
Investors
1
Categories
therapeutics, psychiatry, psychedelics, mental-health, biotech, psilocybin

Investors

NameLocationTypeStagesPortfolio
OMX VenturesSan Francisco, California, USAbiotech-focused
seedseries-a
23